During the past decade, Caritas-Krankenhaus Lebach conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Caritas-Krankenhaus Lebach" #1 sponsor was "University of Ulm" with 7 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "German CLL Study Group" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Caritas-Krankenhaus Lebach" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Caritas-Krankenhaus Lebach" are "Acute Myeloid Leukemia" (7 trials), "Lymphoma" (4 trials), "Acute Myeloid Leukemia (AML)" (3 trials), "Leukemia" (3 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Caritas-Krankenhaus Lebach" in a lesser frequency.

Most popular intervention types in "Caritas-Krankenhaus Lebach" are "Drug" (19 trials), "Biological" (8 trials), "Radiation" (4 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (5 trials), "doxorubicin hydrochloride" (4 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "vincristine sulfate" (4 trials). Other intervention names were less common.

The vast majority of trials in "Caritas-Krankenhaus Lebach" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Caritas-Krankenhaus Lebach". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Caritas-Krankenhaus Lebach, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Caritas-Krankenhaus Lebach, 2 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Caritas-Krankenhaus Lebach has several departments that took part in Clinical trials: "Department of Internal Medicine / Hematology and Oncology, Caritas Hospital Lebach" - 2 trials